Azenta (AZTA) Total Current Liabilities (2010 - 2026)
Azenta's (AZTA) quarterly Total Current Liabilities came in at $272.6 million in Q2 2026, up 10.72% year-over-year from $246.2 million in Q2 2025, and up 5.98% quarter-over-quarter from $257.2 million in Q1 2026.
Analysis
Azenta (AZTA) Total Current Liabilities (2010 - 2026) Analysis & Trends
Azenta (AZTA) has reported Total Current Liabilities for 17 consecutive years, with $272.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Current Liabilities rose 10.72% year-over-year to $272.6 million in Q2 2026; TTM through Jun 2026 was $272.6 million, a 10.72% increase from a year earlier, with the FY2025 full-year figure at $267.2 million, changed N/A from the prior year.
- Total Current Liabilities was $272.6 million for Q2 2026 at Azenta, up from $257.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $618.0 million in Q1 2022 and troughed at $194.9 million in Q2 2022.
- A 5-year average of $248.4 million and a median of $225.8 million in 2022 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities surged 132.63% in 2022 and plunged 65.59% in 2023, its largest moves.
- Over 5 years, Total Current Liabilities stood at $249.0 million in 2022, then decreased by 5.38% to $235.6 million in 2023, then decreased by 14.05% to $202.5 million in 2024, then jumped by 31.94% to $267.2 million in 2025, then rose by 2.01% to $272.6 million in 2026.
- The last three Total Current Liabilities figures came in at $272.6 million (Q2 2026), $257.2 million (Q1 2026), and $267.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 15.07 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 8.11 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 2.29 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 1.58 Bn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 1.28 Bn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 163.70 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | 961.30 Mn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 132.66 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | 118.51 Mn |
| 10 | Azenta | 1.37 Bn | 1.04 Bn | 198.10 Mn | 272.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 272.57 Mn |
| Mar 31, 2026 | 257.19 Mn |
| Dec 31, 2025 | 267.21 Mn |
| Sep 30, 2025 | 237.67 Mn |
| Jun 30, 2025 | 246.17 Mn |
| Mar 31, 2025 | 221.05 Mn |
| Dec 31, 2024 | 202.52 Mn |
| Sep 30, 2024 | 206.09 Mn |
| Jun 30, 2024 | 202.57 Mn |
| Mar 31, 2024 | 203.00 Mn |
| Dec 31, 2023 | 235.62 Mn |
| Sep 30, 2023 | 210.93 Mn |
| Jun 30, 2023 | 203.63 Mn |
| Mar 31, 2023 | 212.64 Mn |
| Dec 31, 2022 | 249.03 Mn |
| Sep 30, 2022 | 230.55 Mn |
| Jun 30, 2022 | 194.93 Mn |
| Mar 31, 2022 | 617.96 Mn |
| Dec 31, 2021 | 341.80 Mn |
| Sep 30, 2021 | 345.09 Mn |